Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US9108959B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9108959-B2 |
| Application number | US-201214002221-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 27, 2012 |
| Priority date | Mar 3, 2011 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.
Opening claim text (preview).
What is claimed is: 1. A process for preparing a compound of the formula I: or a pharmaceutically acceptable salt thereof, which comprises: contacting a compound of the formula II: with an activating agent to form an acid chloride, foll…
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.